Smaller sized doses for perioral treatment than for higher facial applications are utilised because the oral musculature responds more strongly to the exact same BTX-A dosing. Only one planning of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA approval lies in treatments of cervical dystonia. Botox® https://cristianisahn.wikilowdown.com/6932324/the_smart_trick_of_botulinum_toxins_list_that_no_one_is_discussing